Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13
- PMID: 22578462
- PMCID: PMC7127438
- DOI: 10.1016/j.bmcl.2012.04.081
Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13
Abstract
Severe acute respiratory syndrome (SARS) is an infectious disease with a strong potential for transmission upon close personal contact and is caused by the SARS-coronavirus (CoV). However, there are no natural or synthetic compounds currently available that can inhibit SARS-CoV. We examined the inhibitory effects of 64 purified natural compounds against the activity of SARS helicase, nsP13, and the hepatitis C virus (HCV) helicase, NS3h, by conducting fluorescence resonance energy transfer (FRET)-based double-strand (ds) DNA unwinding assay or by using a colorimetry-based ATP hydrolysis assay. While none of the compounds, examined in our study inhibited the DNA unwinding activity or ATPase activity of human HCV helicase protein, we found that myricetin and scutellarein potently inhibit the SARS-CoV helicase protein in vitro by affecting the ATPase activity, but not the unwinding activity, nsP13. In addition, we observed that myricetin and scutellarein did not exhibit cytotoxicity against normal breast epithelial MCF10A cells. Our study demonstrates for the first time that selected naturally-occurring flavonoids, including myricetin and scultellarein might serve as SARS-CoV chemical inhibitors.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Figures




Similar articles
-
Development of chemical inhibitors of the SARS coronavirus: viral helicase as a potential target.Biochem Pharmacol. 2012 Nov 15;84(10):1351-8. doi: 10.1016/j.bcp.2012.08.012. Epub 2012 Aug 23. Biochem Pharmacol. 2012. PMID: 22935448 Free PMC article. Review.
-
Severe acute respiratory syndrome coronavirus replication inhibitor that interferes with the nucleic acid unwinding of the viral helicase.Antimicrob Agents Chemother. 2012 Sep;56(9):4718-28. doi: 10.1128/AAC.00957-12. Epub 2012 Jun 25. Antimicrob Agents Chemother. 2012. PMID: 22733076 Free PMC article.
-
Identification of a Novel Small Molecule Inhibitor Against SARS Coronavirus Helicase.J Microbiol Biotechnol. 2015 Dec 28;25(12):2007-10. doi: 10.4014/jmb.1507.07078. J Microbiol Biotechnol. 2015. PMID: 26387819
-
A high ATP concentration enhances the cooperative translocation of the SARS coronavirus helicase nsP13 in the unwinding of duplex RNA.Sci Rep. 2020 Mar 11;10(1):4481. doi: 10.1038/s41598-020-61432-1. Sci Rep. 2020. PMID: 32161317 Free PMC article.
-
Understanding helicases as a means of virus control.Curr Pharm Des. 2006;12(11):1315-38. doi: 10.2174/138161206776361147. Curr Pharm Des. 2006. PMID: 16611118 Free PMC article. Review.
Cited by
-
The Therapeutic Effect of Traditional Chinese Medicine on Inflammatory Diseases Caused by Virus, Especially on Those Caused by COVID-19.Front Pharmacol. 2021 May 26;12:650425. doi: 10.3389/fphar.2021.650425. eCollection 2021. Front Pharmacol. 2021. PMID: 34122073 Free PMC article. Review.
-
Identification of potential inhibitors of SARS-CoV-2 main protease and spike receptor from 10 important spices through structure-based virtual screening and molecular dynamic study.J Biomol Struct Dyn. 2022 Feb;40(2):941-962. doi: 10.1080/07391102.2020.1819883. Epub 2020 Sep 18. J Biomol Struct Dyn. 2022. PMID: 32948116 Free PMC article.
-
Natural Flavonoids as Potential Angiotensin-Converting Enzyme 2 Inhibitors for Anti-SARS-CoV-2.Molecules. 2020 Sep 1;25(17):3980. doi: 10.3390/molecules25173980. Molecules. 2020. PMID: 32882868 Free PMC article. Review.
-
Discovery of COVID-19 Inhibitors Targeting the SARS-CoV2 Nsp13 Helicase.bioRxiv [Preprint]. 2020 Aug 10:2020.08.09.243246. doi: 10.1101/2020.08.09.243246. bioRxiv. 2020. Update in: J Phys Chem Lett. 2020 Nov 5;11(21):9144-9151. doi: 10.1021/acs.jpclett.0c02421. PMID: 32817950 Free PMC article. Updated. Preprint.
-
Phytomedicines explored under in vitro and in silico studies against coronavirus: An opportunity to develop traditional medicines.S Afr J Bot. 2022 Dec;151:451-483. doi: 10.1016/j.sajb.2022.04.053. Epub 2022 May 2. S Afr J Bot. 2022. PMID: 35530267 Free PMC article. Review.
References
-
- Marra M.A., Jones S.J., Astell C.R., Holt R.A., Brooks-Wilson A., Butterfield Y.S., Khattra J., Asano J.K., Barber S.A., Chan S.Y., Cloutier A., Coughlin S.M., Freeman D., Girn N., Griffith O.L., Leach S.R., Mayo M., McDonald H., Montgomery S.B., Pandoh P.K., Petrescu A.S., Robertson A.G., Schein J.E., Siddiqui A., Smailus D.E., Stott J.M., Yang G.S., Plummer F., Andonov A., Artsob H., Bastien N., Bernard K., Booth T.F., Bowness D., Czub M., Drebot M., Fernando L., Flick R., Garbutt M., Gray M., Grolla A., Jones S., Feldmann H., Meyers A., Kabani A., Li Y., Normand S., Stroher U., Tipples G.A., Tyler S., Vogrig R., Ward D., Watson B., Brunham R.C., Krajden M., Petric M., Skowronski D.M., Upton C., Roper R.L. Science. 2003;300:1399. - PubMed
-
-
Natural compounds used in our study were directly purified from various medicinal plants or purchased from commercial vendor (Chromadex Inc.) (Table 1). The integrity of the individual natural compounds, directly purified from natural plants was confirmed by NMR spectroscopy (More specific information is available upon request.). All natural compounds were dissolved in DMSO at a concentration of 10 mM as a stock solution before experiments.
-
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous